Twist Bioscience Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Twist Bioscience Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3447
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Twist Bioscience Corp (Twist Bioscience) is a DNA specializing and development company that develops DNA products ad DNA synthesis process. The company provides products includes DNA pools for gRNA cloning such as unamplified oligo pools, cloning-ready oligo pools; protein scanning single variant libraries, clonal perfect genes and non-clonal fragments, among others. The company operates in the US, Europe, Israel, and Singapore. Twist Bioscience is headquartered in San Francisco, California, the US.

Twist Bioscience Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Twist Bioscience Raises Additional USD27 Million in Venture Financing 12
Twist Bioscience Raises USD33 Million in Venture Financing 14
Twist Bioscience Raises USD2.6 Million Financing 15
Twist Bioscience Raises USD61 Million in Series D Venture Financing 16
Twist Bioscience Raises USD37 Million in Series C Venture Financing 18
Twist Bioscience Raises USD26 Million in Series B Financing 20
Twist Bioscience Secures USD9.11 Million in Series A Funding 21
Twist Bioscience Raises US$4.7 Million In Series A Financing 22
Partnerships 23
Twist Bioscience and Desktop Genetics Enter into Partnership 23
Genome Compiler Enters into Integration Agreement with Addgene 24
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 25
Equity Offering 26
Twist Bioscience Raises USD50 Million in Private Placement of Shares 26
Twist Bioscience Corp – Key Competitors 27
Twist Bioscience Corp – Key Employees 28
Twist Bioscience Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Strategy And Business Planning 30
Feb 28, 2018: Twist Bioscience Expands North American Presence With Office in San Diego, California 30
Corporate Communications 31
Jun 20, 2018: Twist Bioscience Appoints Jim Thorburn CFO And Aaron Sato As CSO Of Pharma 31
Government and Public Interest 32
Jul 17, 2017: Sphere Fluidics and Partners Win Major InnovateUK Grant to Develop the World’s First Desktop Genome Editing System 32
Product News 33
Jun 18, 2018: Twist Bioscience Expands Human Core Exome and Custom Next-Generation Sequencing Solutions with High Throughput Offering 33
Feb 14, 2018: Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Genomics and Clinical Researchers Conducting Next-Generation Sequencing 34
Other Significant Developments 35
Jul 11, 2017: Quintara Biosciences Partners with Twist Bioscience to Launch New Gene Fragment and Cloning Services, qBlocks and qGenes 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Key Facts 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Twist Bioscience Raises Additional USD27 Million in Venture Financing 12
Twist Bioscience Raises USD33 Million in Venture Financing 14
Twist Bioscience Raises USD2.6 Million Financing 15
Twist Bioscience Raises USD61 Million in Series D Venture Financing 16
Twist Bioscience Raises USD37 Million in Series C Venture Financing 18
Twist Bioscience Raises USD26 Million in Series B Financing 20
Twist Bioscience Secures USD9.11 Million in Series A Funding 21
Twist Bioscience Raises US$4.7 Million In Series A Financing 22
Twist Bioscience and Desktop Genetics Enter into Partnership 23
Genome Compiler Enters into Integration Agreement with Addgene 24
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 25
Twist Bioscience Raises USD50 Million in Private Placement of Shares 26
Twist Bioscience Corp, Key Competitors 27
Twist Bioscience Corp, Key Employees 28
Twist Bioscience Corp, Subsidiaries 29

List of Figures
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Twist Bioscience Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Terumo Corporation:企業の戦略・SWOT・財務分析
    Terumo Corporation - Strategy, SWOT and Corporate Finance Report Summary Terumo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dukat dd (LURA-R-A):企業の財務・戦略的SWOT分析
    Dukat dd (LURA-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Investitionsbank Berlin:企業の戦略・SWOT・財務分析
    Investitionsbank Berlin - Strategy, SWOT and Corporate Finance Report Summary Investitionsbank Berlin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Bank Of East Asia, Limited
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ameresco Inc (AMRC):企業の財務・戦略的SWOT分析
    Ameresco Inc (AMRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CPI Aerostructures, Inc.:企業の戦略・SWOT・財務分析
    CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report Summary CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Campofrio Food Group, S.A.:企業の戦略・SWOT・財務情報
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Insurance and Care NSW:企業の戦略的SWOT分析
    Insurance and Care NSW - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oragenics Inc (OGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Oragenics Inc (Oragenics) focuses on the development and commercialization of novel antibiotics against infectious disease that includes treatments for oral mucositis, healthcare associated infections, obesity and dental disorders. The company develops its product candidates based on various …
  • RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • The Chugoku Electric Power Co Inc:発電所・企業SWOT分析
    The Chugoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Zignago Vetro SpA:企業の戦略・SWOT・財務情報
    Zignago Vetro SpA - Strategy, SWOT and Corporate Finance Report Summary Zignago Vetro SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Innsuites Hospitality Trust:企業の戦略・SWOT・財務分析
    Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report Summary Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kuwait Energy Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Energy Plc (Kuwait Energy) is an independent oil and gas company that carries out exploration, appraisal, development and production of hydrocarbons. The company operates wide range of oil and gas assets in Middle East and North Africa (MENA) region. It has assets across Egypt, Yemen, …
  • South Egypt Drug Industries Co:企業の戦略的SWOT分析
    South Egypt Drug Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • The Tokyo Electric Power Company Holdings., Incorporated:企業の戦略・SWOT・財務分析
    The Tokyo Electric Power Company Holdings., Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Electric Power Company Holdings., Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • CSL Ltd (CSL):製薬・医療:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • Societa Reale Mutua Di Assicurazioni:企業の戦略・SWOT・財務情報
    Societa Reale Mutua Di Assicurazioni - Strategy, SWOT and Corporate Finance Report Summary Societa Reale Mutua Di Assicurazioni - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • PerkinElmer Inc (PKI):医療機器:M&Aディール及び事業提携情報
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company’s major products include cytogenetics reagen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆